Scarica l'app Stockscreener
0.58
7.41%
0.04
Dopo l'orario di chiusura:
.59
0.01
+1.72%
Sangamo Therapeutics Inc Borsa (SGMO) Ultime notizie
What Makes Sangamo (SGMO) a New Buy Stock - sharewise.com
Analyzing Sangamo Therapeutics (NASDAQ:SGMO) & Terns Pharmaceuticals (NASDAQ:TERN) - Defense World
Will Sangamo Therapeutics Inc. stock recover after recent dropGlobal Markets & Weekly Return Optimization Alerts - Newser
Has Sangamo Therapeutics Inc. formed a bullish divergence2025 Price Targets & Reliable Breakout Stock Forecasts - Newser
Sangamo Therapeutics’ SWOT analysis: genomic medicine firm faces cash crunch - Investing.com
What to expect from Sangamo Therapeutics Inc. in the next 30 daysWeekly Profit Report & Weekly Consistent Profit Watchlists - Newser
Sangamo Therapeutics (SGMO.O) Surges 11.3% on Strong KDJ Signal Amid Mixed Biotech Sector Moves - AInvest
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q2 2025 Earnings Call Transcript - Insider Monkey
Risk adjusted return profile for Sangamo Therapeutics Inc. analyzedSmart Chart Forecasting with AI Algorithms - Newser
How Sangamo Therapeutics Inc. stock performs during market volatilityReal-Time AI Sentiment and Price Forecast - Newser
Why Sangamo Therapeutics Inc. stock is on top investor watchlistsSwing Gain Strategy with Entry Forecast - Newser
What institutional flow reveals about Sangamo Therapeutics Inc.Weekly Price Target Forecast and Alerts - Newser
Smart tools for monitoring Sangamo Therapeutics Inc.’s price actionCapital Safe Picks with Consistent Gains - Newser
Sangamo Therapeutics Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Healthcare Sector Analysts Weigh In on Sangamo Biosciences, Pliant Therapeutics, and Zimmer Biomet Holdings - AInvest
Sangamo Therapeutics (SGMO) Reports Q2 Loss, Lags Revenue Estimates - MSN
Transcript : Sangamo Therapeutics, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Sangamo: Q2 Earnings Snapshot - Greenwich Time
Earnings call transcript: Sangamo Therapeutics Q2 2025 earnings miss, stock drops - Investing.com Australia
Sangamo Q2 2025 slides: Neurology pipeline advances amid financial challenges - Investing.com Australia
Sangamo Therapeutics shares fall 4.55% premarket after Q2 revenue misses estimates. - AInvest
Sangamo Therapeutics Inc (SGMO) Q2 2025 Earnings Call Highlights: Promising Fabry Disease ... By GuruFocus - Investing.com Canada
Sangamo Therapeutics 2025 Q2 Earnings Improved Losses Despite Revenue Surge - AInvest
Sangamo Therapeutics Reports Strong Q2 2025 Results - TipRanks
Sangamo Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Sangamo Therapeutics Q2 Misses Revenue Estimates and Reiterates 2025 Guidance — What This Means for Its Strategic Path Forward - AInvest
Sangamo Therapeutics earnings missed by $0.06, revenue fell short of estimates - Investing.com
Sangamo Therapeutics Q2 revenue misses estimates - MarketScreener
Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2025 Financial Results - Yahoo Finance
Sangamo Therapeutics (SGMO) Expected to Announce Earnings on Thursday - Defense World
Sangamo Therapeutics Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView
Sangamo Therapeutics Announces Second Quarter 2025 Earnings CallLife Science Industry News - Zenopa
GSA Capital Partners LLP Boosts Stock Position in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) - Defense World
Is Sangamo Therapeutics Inc. stock overvalued or undervaluedHigh-yield market plays - Jammu Links News
What are Sangamo Therapeutics Inc. company’s key revenue driversBuild a diversified portfolio for steady growth - Jammu Links News
How does Sangamo Therapeutics Inc. compare to its industry peersGet timely alerts on market opportunities - Jammu Links News
Why is Sangamo Therapeutics Inc. stock attracting strong analyst attentionGet daily updates on top-performing stocks - Jammu Links News
What institutional investors are buying Sangamo Therapeutics Inc. stockRapid growth trajectories - Jammu Links News
Does Sangamo Therapeutics Inc. stock perform well during market downturnsBuild wealth faster with consistent investment plans - Jammu Links News
When is Sangamo Therapeutics Inc. stock expected to show significant growthAchieve superior returns with professional insights - Jammu Links News
Is Sangamo Therapeutics Inc. a good long term investmentBuild a portfolio with strong long-term growth - Jammu Links News
What makes Sangamo Therapeutics Inc. stock price move sharplyInvest smarter with daily market updates - Jammu Links News
What drives Sangamo Therapeutics Inc. stock priceInvest smarter with expert stock picks - Jammu Links News
What are the technical indicators suggesting about Sangamo Therapeutics Inc.Free Stock Index Interpretation - Jammu Links News
Sangamo Therapeutics Announces Q2 2025 Earnings Call and Webcast - AInvest
How strong is Sangamo Therapeutics Inc. company’s balance sheetDaily Trading Strategy For Smart Trading - Jammu Links News
Y Intercept Hong Kong Ltd Makes New $47,000 Investment in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) - Defense World
0.41%
0.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):